UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dysfunctional HDL and atherosclerotic cardiovascular disease

Nature reviews cardiology, 2016-01, Vol.13 (1), p.48-60

2016

Volltextzugriff (PDF)

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Circulation (New York, N.Y.), 2012-04, Vol.125 (15), p.1905-1919

2012

Volltextzugriff (PDF)

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.392-410

2011

Volltextzugriff (PDF)

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The New England journal of medicine, 2017-05, Vol.376 (20), p.1933-1942

2017

Volltextzugriff (PDF)

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

European heart journal, 2016-02, Vol.37 (6), p.536-545

2016

Volltextzugriff (PDF)

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Circulation (New York, N.Y.), 2004-07, Vol.110 (2), p.227-239

2004

Volltextzugriff (PDF)

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

Circulation (New York, N.Y.), 2004-01, Vol.109 (3), p.433-438

2004

Volltextzugriff (PDF)

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Journal of the American College of Cardiology, 2004-08, Vol.44 (3), p.720-732

2004

Volltextzugriff (PDF)

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Nature reviews cardiology, 2018-01, Vol.15 (1), p.9-19

2018

Volltextzugriff (PDF)

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet (British edition), 2015-08, Vol.386 (9992), p.452-460

2015

Volltextzugriff (PDF)

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2201-2210

2015

Volltextzugriff (PDF)

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2727-2735

2010

Volltextzugriff (PDF)

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1256-1267

2013

Volltextzugriff (PDF)

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2003-02, Vol.23 (2), p.160-167

2003

Volltextzugriff (PDF)

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Arteriosclerosis, thrombosis, and vascular biology, 2004-02, Vol.24 (2), p.e13

2004

Volltextzugriff (PDF)

Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome

Circulation research, 2014-06, Vol.114 (12), p.1880-1889

2014

Volltextzugriff (PDF)

High-density lipoprotein infusion therapy: A review

Journal of clinical lipidology, 2024-05, Vol.18 (3), p.e374-e383

2024

Volltextzugriff (PDF)

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

The Journal of biological chemistry, 2003-01, Vol.278 (4), p.2563-2570

2003

Volltextzugriff (PDF)

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-03, Vol.24 (3), p.387-391

Brewer, Jr, H Bryan

2004

Volltextzugriff (PDF)

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-10, Vol.24 (10), p.1755-1760

2004

Volltextzugriff (PDF)

Increasing HDL Cholesterol Levels

The New England journal of medicine, 2004-04, Vol.350 (15), p.1491-1494

Brewer, H. Bryan

2004

Volltextzugriff (PDF)

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Arteriosclerosis, thrombosis, and vascular biology, 2004-08, Vol.24 (8), p.e149

2004

Volltextzugriff (PDF)

human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver

Journal of lipid research, 2005-10, Vol.46 (10), p.2151-2167

2005

Volltextzugriff (PDF)

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

The Journal of biological chemistry, 2003-11, Vol.278 (46), p.45062-45071

2003

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(317)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dysfunctional HDL and atherosclerotic cardiovascular disease

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome

High-density lipoprotein infusion therapy: A review

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Increasing HDL Cholesterol Levels

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

Suchergebnisse filtern